Quantium Medical will be attending Arab Health in the Dubai International Convention and Exhibition center (DWTC), from Monday 29th of January to Thursday 1st of February, where they will exhibit their monitors “Conox” and “qCO”, and their “qCON OEM” Board in the Fresenius Kabi stand (H2 C30).
Our objective is to develop non-invasive methods to monitor the patient, allowing the exchange more efficiently, reduce the risk and increase their comfort. Conox is an anesthetic depth monitor manufactured by Quantium Medical and distributed by Fresenius Kabi since 2017. The same monitoring solution can also be made on boards “qCON OEM”, designed to be integrated into a multiparameter monitor. The cardiac output “qCO” monitor completes our product range, estimating blood flow through an impedance signal.
Arab Health is the largest gathering of healthcare and trade professionals in MENA region (Middle East and North Africa). There will be more than 4.200 world’s healthcare companies coming from more than 150 countries. Moreover, 40 pavilions can be visited to see the best that each nation offers.
Additionally, Arab Health features 19 conferences dedicated to leadership and continuous medical education imparted by international speakers covering the broad vision of the most spoken medical specialities and disciplines today.
The Conox is the only monitor measuring both hypnotic and analgesic effect. This innovative monitor helps to detect if the patient should have awareness during their anaesthesia. It also prevents from too deep anaesthesia which could cause Post Operative Cognitive Dysfunction (POCD).
The American Society of Anaesthesiologists annual congress will take place from October 21st to 25th in Boston. Conox will be highlighting on the Anaesthesia Monitoring department with Fresenius Kabi and Quantium Medical.
“ANESTHESIOLOGY® 2017 returns to the city where modern anaesthesia was born, Boston. On October 16, 1846, the world of medicine was forever changed when William T.G. Morton administered the first anaesthetic for a successful surgical procedure at Boston’s Massachusetts General Hospital. Be at the Boston Convention and Exhibition Center on October 21-25 to take full advantage of five information-packed days of learning, networking and discovering the latest in anaesthesia.”
You will find Conox on the Fresenius Kabi booth number 1617.
More information about the event: www.asahq.org/annualmeeting
As you may know Monday 16th October 2017 is World Anaesthesia Day. This year it will be celebrating through the #CountMeIn! campaign. Count Me In! is an initiative to unite anaesthesia providers to raise awareness and support for scaling-up “human resources for anaesthesia”.
The WFSA’s recently launched Global Anaesthesia Workforce Map highlights the anaesthesia workforce shortage crisis. 70 countries had a total anaesthesia provider density of less than 5 per 100,000 population. Without adequate numbers of staff it will be impossible to scale-up anaesthesia provision worldwide, and impossible to ensure safe anaesthesia for all patients.
The European Society of Intensive Care Medicine (ESICM) held its 30th Annual Congress in the Austria Center Vienna (Vienna, Austria).
Fresenius Kabi presented a wide range of products designed for the use in Intensive Care Units and operating rooms. Our depth of anaesthesia monitor, Conox, was part of the exhibition.
During the four days, doctors and other healthcare worldwide professionals came to inform and give us their positive feedback on their experience with Conox.
From here we want to thank you for your welcome and interest.
We will continue to care for life,
Euroanaesthesia 2017 (the European Anaesthesiology Congress) took place in Genève, Switzerland from 2nd to the 4th June and Quantium Medical was actively present in both the scientific and the exhibitor areas. We are grateful for the attention we received.
During the whole congress, Doctor Gambús (clinical expert in the use of electroencephalogram as a measure of anesthetic drug effects, Hospital Clínic de Barcelona) presented the Conox® depth of anesthesia monitor at the Fresenius Kabi’s booth. Conox® comprises cutting edge hardware and digital signal processing technology to measure the two main components of anesthesia by using one single sensor based on the EEG: the hypnotic component with qCON index, which correlates to hypnotic endpoints, and the analgesic component with the qNOX index, which correlates to the predicted concentrations of remifentanil and to the likelihood of movement response to nociception.
We would like to thank all visitors for their time and interest. We will certainly continue working to offer you the best parameters and products for non-invasive patient monitoring.
In 2014, Quantium Medical participated in the prestigious Industrial PhD Programme from the Government of Catalonia (AGAUR DI-2014) and M.Eng. Jesús Escrivá Muñoz started a thesis on Advanced Signal Processing Techniques for Bioimpedance Signals. Our efforts during the last two years of intense work continue to be rewarded since then. Last week, we were notified that our participation in the Transversal Skills Training, a part of the Industrial PhD Programme, placed first due to our excellent performance. “This is another proof of the considerable effort we continuously invest in our staff development and in our research projects”, says Erik Weber Jensen, Chief Scientific Officer and Chief Executive Officer at Quantium Medical.
Further information on the programme can be consulted here:
Fresenius Kabi, a global healthcare company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, has received the CE Mark for the Conox depth of anesthesia monitor.
Conox is a non-invasive depth of anesthesia monitor designed to help anesthesiologists monitor patient brain activity and to rapidly detect how anesthetics are affecting the patient. The Conox anesthesia monitor comprises cutting edge hardware and digital signal processing technology to measure the two main components of anesthesia: the depth of anesthesia and the patient’s reaction to external stimuli. The qCON index of hypnotic effect and the qNOX index for responsiveness are derived from one forehead sensor recording the EEG. The Conox monitor features an innovative design with easy to use graphical interface, touch screen display and easy to apply sensors.
Conox was developed by Barcelona-based Quantium Medical S.L.U., which was acquired by Fresenius Kabi last year. Quantium Medical is a dynamic company focused on the development of non-invasive physiological monitoring and biosignal data processing.
“Quantium Medical’s non-invasive monitoring competence is an excellent fit for Fresenius Kabi with its anesthetics I.V. drugs and infusion technology. The new Conox device will provide high-quality anesthesia monitoring and enhance our solution offering in the operating room and intensive care units,” said Dr. Christian Hauer, President, Medical Devices Division, Fresenius Kabi.
”The acquisition opens a lot of opportunities for Quantium Medical and the employees of the company to bring world class science into innovative medical products with solutions previously unheard-of,” said Erik Weber Jensen, CEO of Quantium Medical
Fresenius Kabi expects to begin offering the Conox monitor in February 2017.
For questions please contact:
Name: Rebecca Zhou
Phone: (+34) 702 19 50
About Fresenius Kabi:
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.
With its corporate philosophy of “caring for life”, the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. For more information, please visit www.fresenius-kabi.com.
Quantium Medical will be attending Arab Health from next Monday 30 January to Thursday, 2 February.
Join us at booth R.A58, next to IBIS and Novotel Hotel.
Arab Health is the largest gathering of healthcare and trade professionals in the MENA region. Explore 4.400 of the world’s leading healthcare companies coming in from 70 countries. Moreover, browse through more than 38 dedicated country pavilions to see the best that each nation has to offer.
The Arab Health Congress 2017 features 14 conferences offering CME points to attending medical professionals. The conference programme brings a global appeal with international speakers covering a broad spectrum of medical specialties and disciplines on the latest healthcare issues and topics. View the 2017 conference list.
Danish scientist Erik Weber Jensen, Quantium Medical’s President, in 1991 came up with Auditory Evoked Potentials (AEP) concept, with the continue focusing in development consciousness of anesthesia monitoring technology more than 20 years now.
Dr. Erik Weber Jensen has been invited as a guest speaker at the 16 th Word Congress of Anesthesiologists that held in Hongkong between 28th August and 2nd September 2016. Meanwhile on behalf of Quantium Medical he presented the latest depth of anesthesia monitor named qCON 3000 that with both sedation and nociception monitoring parameters, and also the advanced technology -Noninvasive cardiac output- qCO in this world congress, we are happy to see our products has been received highly attention among the visitors.
We would like to thank for all visitors’ time and interest.
We are looking forward to see you again at the NAVAt (Belgium) and ISAP 25th Annual Meeting in Chicago on 21st October.
QM attended at the Florida International Medical Equipment (FIME) tradeshow. This event represents a gathering point for manufacturers and distributors for US and Latin America. It is a 3 day event (from 2nd August to the 4th August 2016) for showcasing products from the Medical & Pharmaceutical industry.
Quantium Medial was doing a lot of interesting meetings with potential new distributors and manufacturers for this region.
We would like to thank all visitors for their time and interest.
See you at WCA in Honk Hong next week!
Tomorrow, April,22 will take place the symposium entitled “New Developments in Minimal Invasive Pain Management & Anesthesia Monitoring” where Erik Weber Jensen, our CEO, will participate with two presentation:
– 02:30-03:00 PM: Tailoring the Hypnotic and Analgesic Effects with the qCON and qNOX indices
– 03:00-03:30 PM: Easy Monitoring of Cardiac Output for All Patients with the qCO.
Other speakers will be Dr. OJJM Rohof from Amsterdam and Dr. H.P. van Driel from Rotterdam.
All attendees will be welcomed.
Further information: Click here
Last week, the main medical device fair in the Middle East, Arab Health, was held in Dubai. Arab Health is a 4 day event(from 25th January to the 28th January 2016) for showcasing products from the Medical & Pharmaceutical industry.
This year, Quantium Medical has used the fair in order to show a new product, the qCO, a noninvasive monitor for the cardiac output measurement . Several companies showed their interest in the qCO because it can make a quick measure of Cardiac Output in the critical patients and no increases the risk possible.
Quantium Medical would like to thank all visitors for their time and interest. See you in Euroneuro in Barcelona next April!
Last week, some members of Quantium Medical, including the company President, Erik Weber Jensen, attended at the Spanish Society of Anaesthesia and Recovery congress (SEDAR) supporting MBA, its spanish partner.
MBA’s booth was one of the largest and was located in the central part of the room. As you can see in the picture, half booth was dedicated exclusively to the qCON2000.
We would like to thank the spanish doctors for their time, patience and their desire to prosper. As well we have to thanks the MBA employers, who are doing a good job in the differents areas of Spain. Their motivation and dedication help us, day by day, to grow and keep developping new non invasive monitors to improve the quirurgical proceses and reduce the patient risk.
Quantium Medical has received the prestigious Torres Quevedo grant to empower it’s R&D activities in pain and nociception monitoring.
The goal of the Torres Quevedo grants is to promote the capacity to carry out industrial research, experimental development of technical viability projects in order to stimulate the incorporation of high qualified staff in private companies and support the consolidation and development of technology based companies recently created.
Quantium Medical Research engineer Umberto Melia is coauthor in prize awarded abstract at the Society of Anaesthesia and Sleep medicine’s annual meeting. The title of the abstract is “Is the alpha frequency band of the EEG a marker of unconsciousness during sedation with propofol and remifentanil? The influence of aging”. The annual meeting will be celebrated October 22-23 at Hilton Hotel in San Diego, California.
Further information: http://sasmhq.org/2015-annual-meeting/
Quantium Medical is looking forward to attend the ASA, the ANESTHESIOLOGY 2015 annual meeting celebrated in San Diego California October 24-28. Five days to learn about the specialty’s latest science and technologies and share our ideas and products with the 15,000 attendees from around the world. In this year’s scientific program offering 600 sessions, special lectures and hands-on workshops.
Send an email to email@example.com to schedule a appointment!
Further information: http://www.asahq.org/Annual%20Meeting/
Erik Weber Jensen, CEO of Quantium Medical, will attend at the SFAR (Societé Française d’Anesthésie et Réanimation) congress which will be taking place 17-19 September in Paris,. During this congress will be many sesion divided en five themes:
– General topics
Don’t hesitate to attend if you have the possibility.
Further information: http://www.sfar2015.com/
Quantium Medical was chosen as an example of successful business in Mataró. For this reason, a video was recorded in order to help to impulse the business creation. Erik Weber Jensen, CEO of Quantium Medical, explains the benefits of this business friendly city and the advantages that this localitate has given along the years.
Euroanaesthesia 2015 (The European Anaesthesiology Congress) took place in Berlin, Germany from 30 May to 2 June. This year, like last year, Quantium Medical took part actively in both the scientific and the exhibitor area. We are grateful for the great attention received.
In respect to the scientific program, an abstract of each one our main products were presented. Two abstracts, about the qNOX and the qCO, were presented by members of Quantium Medical and one about the qCON by Dr. Zanner, who presented the results of data replayed to the qCON to assess update time.. The first abstract, about the qNOX, was presented by our CSO and CEO, Erik Weber Jensen. The purpose of this study was to validate which of two qNOX versions was able to predict response to laryngoscopy and LMA insertion. The study was done with 140 patients at the Hospital Clinic of Barcelona. The conclusion was that both versions were able to predict the response to the LMA placement and, for prediction of response to laryngoscopy, only the new version was able to predict movement with post stimuli values. A vast number of delegates showed interest in the qCON 2000 because it offers the possibility to monitor the hypnotic effect and the balance nociception/anti-nociception from one unique sensor. The other abstract, presented by Jesus Escrivá, was his first abstract in a long way to earn his doctorate and the first abstract using the qCO during general anaesthesia. The study included 26 patients to show significant differences between the Cardiac Output in awake and anaesthetised patients. See the abstracts in the Clinical Results.
In parallel, Quantium Medical was sharing its stand with some of its distributors, Medec from Belgium, Kommed from Germany and Unimedics from South Korea. The stand presented a bright-colored design, where the qCO, qCON, qNOX and its devices were represented. During all congress the stand received a lot of visits of people around the world. The Quantium Medical team have transmitted all feedbacks and advices, we are grateful for all and we hope to see you soon.
Many thanks to all the attendants, we will continue working to offer you new parameters and products for patient monitoring.
Quantium Medical will present products, ideas and clinical science at the upcoming ESA meeting in Berlin. Quantium Medical will be at booth #91 . Here you can also find some of our distributors , Medec from Belgium, Kommed from Germany and Unimedics from South Korea. Two abstracts will be presented on the qCON and one on the qCO.
Quantium Medical is devoted to bring the best information to our customers. We are proud to present our new website, with improved navigation, more information, and seamless connection whether you login from a PC, tablet or smartphone.
You’ll find comprehensive sections for all of our products, with everything you need to know whether you are an existing Quantium Medical client or you are interested in learning more about us. In our Products pages, you’ll find specific information on:
· Our depth of anaesthesia monitor, the qCON 2000, which contains the qCON index of hypnotic effect and the qNOX index of nociception.
· The qCO is designed to estimate cardiac output during anaesthesia, sedation and intensive care. It applies an Adaptive Neuro Fuzzy Inference System (ANFIS) which combines various input parameters (impedance, age, body mass index) to achieve a more precise measurement.
In the clinical results section you will find summaries of the clinical studies published so far.
The Chief Scientific Officer of Quantium Medical, Erik Weber Jensen is invited speaker at the NAVAt 2015 (Aalst, Belgium) 19th of September 2015. He will introduce the latest science on qCON and qNOX in his presentation titled: “CORTICAL ELECTRICAL PHENOMENA TO TITRATE DEPTH OF ANESTHESIA: THE qCON and qNOX.” This symposium meets every year the best anaesthesia researchers of the world so we are proud to be present and we strongly recommend your attendance.
Further information about NAVAt 2015:
Quantium Medical has achieved the coveted Industrial Doctoral grant from the Government of Catalonia (AGAUR DI-2014). The title of the project is “Development of a system for monitoring the responses to nociceptive stimuli during anaesthesia based on neurophysiological signals”. The project strengthens Quantium’s already strong expertise and leadership in monitoring nociception during anaesthesia by EEG. The project will be conducted by Jesús Escrivá Muñoz . In 2009, Jesús Escrivá was awarded the prize “Best Student” in the 2009 promotion of Technical Engineering in Telecommunications by Universitat Politècnica de València. During his bachelor, he also studied in universities in Italy and Hong Kong as an exchange students thanks to an Erasmus scholarship. Between 2009 and 2012, he ranked 5th out of 112 students in the degree of Engineering of Telecommunications, where he specialized in biomedical signals and signal treatment in Valencia. “We are very happy to welcome Jesús Escrivá to our world class R&D group, says Erik Weber Jensen, Chief Scientific Officer at Quantium”
Further information on the programme can be consulted here::
February, 16, 2015
Quantium Medical participated in the Arab Health 2015, where it had the chance of show the qCON2000 to a lot of visitors.
Quantium medical is most grateful for the great attention that it has received this year.
We are looking forward to attending the next year!
Further information about Quantium Medical in our linkedin